As of the latest SEC filings, Calidi Biotherapeutics, Inc. (CLDI) is held by 5 institutional funds. The largest fund shareholder is Fidelity Extended Market Index Fund (FSMAX), holding an estimated $23,496.21 in market value, representing a significant portion of its portfolio.
Funds holding Calidi Biotherapeutics, Inc. (CLDI)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- CLDI
- CIK:
- 0001855485
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $23,496.21 | 29,568 | Feb 28, 2026 | Apr 24, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $6,091.55 | 25,509 | Mar 31, 2026 | May 28, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $4,092.45 | 5,150 | Feb 28, 2026 | Apr 24, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $3,690.35 | 4,644 | Feb 28, 2026 | Apr 24, 2026 |
|
BXMYX
Blackstone Alternative Multi-Strategy Fund
|
MF | Independent / Boutique | 0.00% | -$3.82 | -16 | Mar 31, 2026 | May 27, 2026 |
Advertisement (320x50)